Urpu Salmenniemi

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 97 publications

Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.

Impact of conditioning regimen on outcomes of young AML patients ( < 40 years) undergoing HCT in complete remission, with transplant conditioning intensity score of 3.5-4.0. A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation.

Journal: Bone marrow transplantation

Published: March 21, 2026

Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties.

Secondary autoimmune and inflammatory diseases after allogeneic hematopoietic stem cell transplantation: a retrospective study from the EBMT transplant complications and autoimmune diseases working parties.

Journal: Bone marrow transplantation

Published: January 21, 2026

Single-Cell Analysis of Adaptive NK and CMV-Specific T Cell Dynamics after Allogeneic HSCT.

Single-Cell Analysis of Adaptive NK and CMV-Specific T Cell Dynamics after Allogeneic HSCT.

Journal: Blood advances

Published: January 20, 2026

Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT.

Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT.

Journal: Blood advances

Published: January 20, 2026

Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party.

Complications of Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-A Prospective Study on Behalf of the EBMT Transplant Complications Working Party.

Journal: Cancers

Published: December 02, 2025

Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).

Outcomes of 544 Patients with t(6;9)/DEK::NUP214 acute myeloid leukemia undergoing allogeneic stem cell transplantation: an EBMT study on behalf of the acute leukemia working party (ALWP) and the pediatric diseases working party (PDWP).

Journal: Bone marrow transplantation

Published: November 04, 2025

Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT.

Decreased Chronic GvHD With Post-Transplant Cyclophosphamide Versus ATG in Patients With Myelofibrosis Allografted With an Unrelated Donor: A Study From the Chronic Malignancies Working Party of the EBMT.

Journal: American journal of hematology

Published: October 10, 2025

Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 Disease.

Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 Disease.

Journal: Blood advances

Published: September 09, 2025

Allogeneic hematopoietic stem cell transplantation in ERCC6L2 disease.

Allogeneic hematopoietic stem cell transplantation in ERCC6L2 disease.

Journal: Blood advances

Published: September 09, 2025

A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithm.

Journal: Bone marrow transplantation

Published: September 05, 2025

Impact of MICA-129 Mismatch on Hematopoietic Stem Cell Transplantation Outcomes: Evidence from a Large European Cohort and Meta-Analysis.

Impact of MICA-129 Mismatch on Hematopoietic Stem Cell Transplantation Outcomes: Evidence from a Large European Cohort and Meta-Analysis.

Journal: Transplantation and cellular therapy

Published: August 26, 2025

Landscapes of HLA Mismatching in Contemporary Unrelated Haematopoietic Cell Transplantation.

Landscapes of HLA Mismatching in Contemporary Unrelated Haematopoietic Cell Transplantation.

Journal: HLA

Published: July 09, 2025

Showing 1-12 of 97

Last Updated: 09/26/2026